KEY vs PRLD · P/E 13, rev $7.51B vs rev $6.5M
KeyCorp (KEY) versus Prelude Therapeutics Inc (PRLD) — a side-by-side from cached financials, not a winner call.
KeyCorp (KEY) is a banks - regional company listed on US.
Prelude Therapeutics Inc (PRLD) is a biotechnology company listed on NASDAQ.
Latest reported KEY revenue for 2025-12-31 was $7.51B. Net income was $1.83B. Revenue was up 62.7% from 2024-12-31 to 2025-12-31. KEY currently screens at market cap $22.64B and trailing P/E 12.8.
Latest reported PRLD revenue for 2025-09-30 was $6.5M. Net income was -$83.0M. Revenue was up 116.7% from 2024-09-30 to 2025-09-30. PRLD currently screens at market cap $346.5M.
KEY currently screens at market cap $22.64B and trailing P/E 12.8. PRLD currently screens at market cap $346.5M.
Not investment advice. Open the KEY and PRLD stock pages for the full models.
Not investment advice.